Shengliang Ye

417 total citations
28 papers, 273 citations indexed

About

Shengliang Ye is a scholar working on Molecular Biology, Hematology and Management of Technology and Innovation. According to data from OpenAlex, Shengliang Ye has authored 28 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Hematology and 5 papers in Management of Technology and Innovation. Recurrent topics in Shengliang Ye's work include Blood donation and transfusion practices (5 papers), Blood groups and transfusion (5 papers) and Platelet Disorders and Treatments (4 papers). Shengliang Ye is often cited by papers focused on Blood donation and transfusion practices (5 papers), Blood groups and transfusion (5 papers) and Platelet Disorders and Treatments (4 papers). Shengliang Ye collaborates with scholars based in China and United States. Shengliang Ye's co-authors include Xi Du, Zongkui Wang, Haijun Cao, Fengjuan Liu, Rong Zhang, Peng Jiang, Li Ma, Changqing Li, Pan Sun and Changqing Li and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Proteome Research and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Shengliang Ye

25 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shengliang Ye China	10	113	68	34	30	29	28	273
Meeta Yadav United States	9	206 1.8×	31 0.5×	55 1.6×	19 0.6×	34 1.2×	17	339
Yitang Sun United States	11	76 0.7×	69 1.0×	15 0.4×	31 1.0×	39 1.3×	20	344
Nana Ping China	11	78 0.7×	57 0.8×	63 1.9×	48 1.6×	32 1.1×	32	354
Xue Qin China	11	92 0.8×	19 0.3×	21 0.6×	35 1.2×	23 0.8×	42	289
Shaxi Ouyang China	8	148 1.3×	21 0.3×	10 0.3×	32 1.1×	33 1.1×	15	279
Prabhash Kumar Jha India	9	114 1.0×	34 0.5×	25 0.7×	33 1.1×	10 0.3×	17	236
Lkhagvasuren Munkhtulga Japan	9	197 1.7×	50 0.7×	22 0.6×	43 1.4×	68 2.3×	16	359
Vishruth K. Reddy United States	11	124 1.1×	71 1.0×	9 0.3×	62 2.1×	21 0.7×	28	433
Anna Kieronska‐Rudek Poland	9	93 0.8×	20 0.3×	14 0.4×	35 1.2×	50 1.7×	17	282

Countries citing papers authored by Shengliang Ye

Since Specialization

Citations

This map shows the geographic impact of Shengliang Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengliang Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengliang Ye more than expected).

Fields of papers citing papers by Shengliang Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengliang Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengliang Ye. The network helps show where Shengliang Ye may publish in the future.

Co-authorship network of co-authors of Shengliang Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Shengliang Ye. A scholar is included among the top collaborators of Shengliang Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengliang Ye. Shengliang Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Xiao-Chen, Peng Jiang, Changqing Li, et al.. (2024). Intravenous immunoglobulin ameliorates doxorubicin-induced intestinal mucositis by inhibiting the Syk/PI3K/Akt axis and ferroptosis. APOPTOSIS. 30(3-4). 734–750. 3 indexed citations

Zhu, Liyuan, Li Ma, Zongkui Wang, et al.. (2023). Blood Service in a Region of China’s Qinghai–Tibetan Plateau. Healthcare. 11(13). 1944–1944.

Zhang, Wei, Zongkui Wang, Shengliang Ye, et al.. (2023). Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG). International Journal of Molecular Sciences. 24(21). 15993–15993. 2 indexed citations

Liu, Bin, Zongkui Wang, Yang Gao, et al.. (2022). Analysis of influencing factors of serum total protein and serum calcium content in plasma donors. PeerJ. 10. e14474–e14474. 2 indexed citations

Zhang, Rong, Fengjuan Liu, Shengliang Ye, et al.. (2022). Proteomics profiles of blood glucose-related proteins involved in a Chinese longevity cohort. Clinical Proteomics. 19(1). 45–45. 4 indexed citations

Liu, Fengjuan, Shengliang Ye, Peng Jiang, et al.. (2022). The proteome profiling of EVs originating from senescent cell model using quantitative proteomics and parallel reaction monitoring. Journal of Proteomics. 266. 104669–104669.

Du, Xi, Zongkui Wang, Li Ma, et al.. (2020). Content of anti-β-amyloid42 oligomers antibodies in multiple batches from different immunoglobulin preparations. Biologicals. 65. 25–32. 1 indexed citations

Ye, Shengliang, Li Ma, Rong Zhang, et al.. (2019). Plasma proteomic and autoantibody profiles reveal the proteomic characteristics involved in longevity families in Bama, China. Clinical Proteomics. 16(1). 22–22. 13 indexed citations

Wang, Zongkui, Fengjuan Liu, Peng Jiang, et al.. (2018). GDF11 induces differentiation and apoptosis and inhibits migration of C17.2 neural stem cells via modulating MAPK signaling pathway. PeerJ. 6. e5524–e5524. 18 indexed citations

10.

Wang, Zongkui, Fengjuan Liu, Shengliang Ye, et al.. (2018). Plasma proteome profiling of high-altitude polycythemia using TMT-based quantitative proteomics approach. Journal of Proteomics. 194. 60–69. 41 indexed citations

11.

Wang, Zongkui, Rong Zhang, Fengjuan Liu, et al.. (2018). TMT‐Based Quantitative Proteomic Analysis Reveals Proteomic Changes Involved in Longevity. PROTEOMICS - CLINICAL APPLICATIONS. 13(4). e1800024–e1800024. 22 indexed citations

12.

Ye, Shengliang, Dong Li, Fengjuan Liu, et al.. (2018). In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations. Journal of Pharmaceutical and Biomedical Analysis. 151. 317–323. 4 indexed citations

13.

Wang, Zongkui, Xi Du, Li Ma, et al.. (2017). Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population. PeerJ. 5. e3156–e3156. 31 indexed citations

14.

Ye, Shengliang, Peng Jiang, Fengjuan Liu, et al.. (2016). Demonstration of the IgG antibody repertoire against the bacteria Escherichia coli in Chinese intravenous immunoglobulins. Journal of Pharmaceutical and Biomedical Analysis. 133. 8–14. 8 indexed citations

15.

Sun, Pan, Hongjie Wang, Rong Xia, et al.. (2015). Prevalence of hepatitis E virus in Chinese blood donors. Journal of International Medical Research. 43(2). 257–262. 14 indexed citations

16.

Wang, Zongkui, et al.. (2014). Coagulation factors and inhibitors in thawed plasma stored at 1–6°C for 5days in China. Transfusion and Apheresis Science. 50(2). 274–280. 9 indexed citations

17.

Zhang, Xuejun, et al.. (2013). Chinese plasma-derived products supply under the lot release management system in 2007–2011. Biologicals. 41(6). 364–367. 4 indexed citations

18.

Cao, Haijun, Changqing Li, Yun Huang, et al.. (2013). INFLUENCE OF WASHING CONDITIONS ON EFFECTIVE COMPONENTS OF PROTHROMBIN COMPLEX CONCENTRATES. Preparative Biochemistry & Biotechnology. 44(2). 164–181.

19.

Hou, Yiling, Xiang Ding, Shengliang Ye, et al.. (2013). PURIFICATION AND ANALYSIS OF HUMAN ALPHA₁-ANTITRYPSIN CONCENTRATE BY A NEW IMMUNOAFFINITY CHROMATOGRAPHY. Preparative Biochemistry & Biotechnology. 44(7). 725–737. 9 indexed citations

20.

Hou, Pei, Jihai Gao, Ningfei Lei, et al.. (2010). Different Functions and Expression Profiles of Curcin and Curcin-L in Jatropha curcas L.. Zeitschrift für Naturforschung C. 65(5-6). 355–362. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact